Rising Incidence Of Infectious Diseases Fuels Growth Of The Market: A Key Driver Powering CRISPR-Based Diagnostics Market Growth In 2025

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Current CRISPR-Based Diagnostics Market Size and Its Estimated Growth Rate?
The dimension of the market for diagnostics based on CRISPR technology has seen a significant surge lately. It is projected to expand from a worth of $4.35 billion in 2024 to a value of $5.14 billion in 2025, marking a compound annual growth rate (CAGR) of 18.1%. Factors such as increased spending on healthcare, amplified demand for gene manipulation, a growing occurrence and incidence rate of chronic diseases, heightened awareness of treatment options, and a surge in the commonality of genetic disorders are responsible for this growth trend in the historical period.

The market for CRISPR-based diagnostics is predicted to experience swift expansion in the coming years, reaching a value of $9.92 billion in 2029, with a CAGR of 17.9%. The projected growth during the forecast period can be linked to an increasing need for quick and precise diagnostic methods, expanding applications in identifying infectious diseases, surge in government and institutional funding, enhanced identification of antibiotic resistance, and a rising consciousness and acknowledgement of CRISPR technologies. Key trends expected during the projection period encompass point-of-care (POC) testing, integration of CRISPR-Cas12 and Cas13 systems, advancement in personalized medicine and genetic screening, assimilation with nanotechnology and biosensors, and early disease detection via CRISPR.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20734

How Are Emerging Segments Shaping the CRISPR-Based Diagnostics Market Landscape?
The CRISPR-based diagnostics market covered in this report is segmented -

1) By Product: Kits, Buffer Solutions, Software, Other Products
2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Other Techniques
3) By Disease: Infectious Diseases, Non-Infectious Diseases
4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits
2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers
3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software
4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp

Which Growth Factors Are Influencing CRISPR-Based Diagnostics Market Expansion?
The escalating prevalence of infectious diseases is anticipated to fuel the expansion of the CRISPR-based diagnostics market in the future. These diseases are triggered by harmful microorganisms such as bacteria, viruses, fungi, or parasites and can be transmitted directly or indirectly between individuals, via contaminated objects, food, water, or carriers such as insects. The prevalence of infectious diseases is escalating due to elements like globalization, antibiotic resistance, climate change, urbanization, population surge, habitat devastation, and inadequate healthcare facilities. By providing quick and precise detection of pathogens, CRISPR-based diagnostics bolster the battle against infectious diseases, enabling early detection, prompt attention, and efficient containment strategies. For example, in August 2024, the UK Health Security Agency (UKHSA), an executive agency based in the UK, documented 368 cases of measles in 2023, a nearly seven times increase compared to the 53 cases reported in 2022. The West Midlands and London accounted for 44% and 33% of these cases respectively. Consequently, the growing prevalence of infectious diseases is a driving factor for the growth of the CRISPR-based diagnostics market.

Who Are the Dominant Players Across Different CRISPR-Based Diagnostics Market Segments?
Major companies operating in the CRISPR-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc.

What Are the Latest Developing Trends in the Acne Treatment Devices Market?
The primary players in the CRISPR-based diagnostic sector are concentrating their efforts on forming strategic alliances to increase the accessibility of prompt and precise diagnostic solutions via CRISPR-based point-of-care exams. A strategic alliance is a lasting cooperation between two or more firms, where they pool their resources and knowledge to achieve shared objectives and improve their competitive edge. For example, in August 2023, CrisprBits Private Limited, a biotech company from India, disclosed that it was entering into a strategic partnership with Molbio Diagnostics, a molecular diagnostics firm also based in India. The collaboration aims to develop CRISPR-based Point-of-Care Tests (POCTs). Their focus is on designing quick, accurate, and cost-friendly diagnostic instruments that harness CRISPR technology for the detection of pathogens and genetic markers. Their POCTs aim to improve diagnostic reach in various settings, including areas with limited resources, while guaranteeing swift and precise disease diagnosis. The alliance merges CrisprBits' proficiency in CRISPR-based platforms with Molbio's production and distribution prowess to make these exams available worldwide.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Geographic Regions Are Expected to Dominate the CRISPR-Based Diagnostics Market in the Coming Years?
North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the CRISPR-Based Diagnostics Market?
2. What is the CAGR expected in the CRISPR-Based Diagnostics Market?
3. What Are the Key Innovations Transforming the CRISPR-Based Diagnostics Industry?
4. Which Region Is Leading the CRISPR-Based Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.